Viking Therapeutics, Inc.
VKTXDrugs in Pipeline
3
Phase 3 Programs
1
Upcoming Catalysts
2
Next Catalyst
Oct 31, 2026
12wMarket Overview
Stock performance and key metrics
2 upcoming, 1 past
How VKTX's past catalysts played out
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in Viking Therapeutics, Inc.'s drug pipeline?→
CatalystAlert tracks 3 drug candidates in Viking Therapeutics, Inc.'s (VKTX) pipeline across Phase 3, Phase 2. Its lead program is VK2735 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Viking Therapeutics, Inc.'s next FDA catalyst?→
Viking Therapeutics, Inc.'s (VKTX) next tracked catalyst is a Earnings expected July 29, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track VKTX biotech catalysts?→
Add VKTX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Viking Therapeutics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.